🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tzu‐Chun Cheng

China Medical University

ORCID: 0009-0006-9922-331X

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “RNA four-way junction (4WJ) for spontaneous cancer-targeting, effective tumor-regression, metastasis suppression, fast renal excretion and undetectable toxicity”.

RNA four-way junction (4WJ) for spontaneous cancer-targeting, effective tumor-regression, metastasis suppression, fast renal excretion and undetectable toxicity

Biomaterials(2023)10.1016/j.biomaterials.2023.122432

N/A

0DataRank · unranked

22 citations

Kai Jin, Tzu‐Chun Cheng, You-Cheng Liao, Wen-Jui Lee, Abhjeet S. Bhullar +6 more

In Vitro and In Vivo Evaluation of the Pathology and Safety Aspects of Three- and Four-Way Junction RNA Nanoparticles

Molecular Pharmaceutics(2024)10.1021/acs.molpharmaceut.3c00845

N/A

0DataRank · unranked

11 citations

You-Cheng Liao, Tzu‐Chun Cheng, Xin Li, Wen-Jui Lee, Fengmei Pi +6 more

RNA Nanotechnology for Codelivering High-Payload Nucleoside Analogs to Cancer with a Synergetic Effect

Molecular Pharmaceutics(2024)10.1021/acs.molpharmaceut.4c00674

N/A

0DataRank · unranked

5 citations

Kai Jin, You-Cheng Liao, Wen-Jui Lee, Li-Ching Chen, Tzu‐Chun Cheng +3 more

Targeted Delivery of Potent Chemical Drugs and RNAi to Drug-Resistant Breast Cancer Using RNA-Nanotechnology and RNA-Ligand Displaying Extracellular vesicles

RNA NanoMed(2024)10.59566/isrnn.2024.0101016

N/A

0DataRank · unranked

4 citations

Peixuan Guo, Tzu‐Chun Cheng, Yuan Soon Ho